Takeda Feels Need For Speed In Approaching Shire Integration

Takeda has fleshed out several aspects of its planned acquisition of Shire, emphasizing the need for speed and decisiveness if the integration is to be successful, although investors may need more reassurance ahead of required shareholder approval. 

map
TAKEDA FLESHES OUT SHIRE PROPOSAL BUT MORE CONVINCING NEEDED? • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd.'s $62bn planned acquisition of Shire PLC may be moving ahead - pending shareholder approval - but in many ways the hard work is just beginning, even after a protracted pursuit that saw the Japanese firm raise its bid five times before final success.

While the acquisition of a late-stage pipeline and products in new niche areas are being seen as the main benefits...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia